SG10201909517WA - Learning and memory improver - Google Patents

Learning and memory improver

Info

Publication number
SG10201909517WA
SG10201909517WA SG10201909517WA SG10201909517WA SG 10201909517W A SG10201909517W A SG 10201909517WA SG 10201909517W A SG10201909517W A SG 10201909517WA SG 10201909517W A SG10201909517W A SG 10201909517WA
Authority
SG
Singapore
Prior art keywords
memory
learning
agents
present
improver
Prior art date
Application number
Inventor
Nobuo Tsuruoka
Hiroshi Watanabe
Original Assignee
Suntory Holdings Ltd
Suntory Beverage & Food Asia Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd, Suntory Beverage & Food Asia Pte Ltd filed Critical Suntory Holdings Ltd
Publication of SG10201909517WA publication Critical patent/SG10201909517WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LEARNINGAND MEMORY IMPROVER The present invention aims to provide antidementia agents which are free from the problem of side effects and are excellent in safety. The present invention also aims to provide agents for improving learning and memory which are useful for improvement of learning and memory and can be ingested continuously. The present invention provides antidementia agents and agents for improving learning and memory, each comprising a cyclic dipeptide with the ,5-diketopiperazine structure as an active ingredient.
SG10201909517W 2012-11-21 2013-11-21 Learning and memory improver SG10201909517WA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012255047A JP6291158B2 (en) 2012-11-21 2012-11-21 Nootropics and learning memory improvers

Publications (1)

Publication Number Publication Date
SG10201909517WA true SG10201909517WA (en) 2019-11-28

Family

ID=50776151

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201909517W SG10201909517WA (en) 2012-11-21 2013-11-21 Learning and memory improver
SG11201503967QA SG11201503967QA (en) 2012-11-21 2013-11-21 Learning and memory improver

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201503967QA SG11201503967QA (en) 2012-11-21 2013-11-21 Learning and memory improver

Country Status (13)

Country Link
US (1) US9877960B2 (en)
JP (1) JP6291158B2 (en)
KR (1) KR102142168B1 (en)
CN (1) CN104936597B (en)
AU (1) AU2013348836B2 (en)
GB (1) GB2523044B (en)
HK (1) HK1211212A1 (en)
MY (1) MY183914A (en)
NZ (1) NZ708648A (en)
PH (1) PH12015501115A1 (en)
SG (2) SG10201909517WA (en)
TW (1) TWI620564B (en)
WO (1) WO2014080973A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA034419B1 (en) * 2014-09-26 2020-02-06 Хьюман Метаболоми Текнолоджис Инк. Method for predicting options of a depression treatment drug
WO2017010133A1 (en) * 2015-07-16 2017-01-19 サントリーホールディングス株式会社 Composition that contains plant- or animal-derived peptide and inhibits serum carnosinase
TW201733608A (en) * 2016-01-08 2017-10-01 Suntory Holdings Ltd Cyclic dipeptide-containing composition for preventing neurological diseases
WO2017209156A1 (en) 2016-05-31 2017-12-07 森永乳業株式会社 Brain function improving agent
US11162128B1 (en) * 2017-05-23 2021-11-02 The United States Of America As Represented By The Secretary Of The Army Mass spectrometry ionization based-assay for the detection of enzyme activity and/or presence
CN116685343A (en) * 2020-12-18 2023-09-01 三得利控股株式会社 Use of cyclic dipeptides for the manufacture of agents that inhibit cognitive decline or improve cognitive dysfunction
CN113940286A (en) * 2021-09-30 2022-01-18 南通大学 Method for training and improving space learning capacity of mouse
WO2023120407A1 (en) * 2021-12-23 2023-06-29 サントリーホールディングス株式会社 COMPOSITION FOR SUPPRESSING PRODUCTION AND/OR ACCUMULATION OF AMYLOID β

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3830096A1 (en) 1988-09-03 1990-03-15 Hoechst Ag PIPERAZINDIONE WITH PSYCHOTROPER EFFECT
JP4215857B2 (en) 1998-03-26 2009-01-28 裕 大村 Learning / memory ability improver
JP2003221337A (en) * 2002-01-29 2003-08-05 Dainippon Pharmaceut Co Ltd Dementia treating agent containing acetamide derivative as active component
WO2003101927A1 (en) * 2002-05-31 2003-12-11 Proteotech, Inc. Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
JP2008255087A (en) 2007-03-13 2008-10-23 Kyowa Hakko Kogyo Co Ltd Locomotor activity promotor
SG178211A1 (en) 2009-12-25 2012-03-29 Suntory Holdings Ltd Extracts and beverages containing 2, 5-piperazinedione, 3, 6-bis (phenylmethyl) -, (3s, 6s) -
JP4901950B2 (en) * 2009-12-25 2012-03-21 サントリーホールディングス株式会社 Acidic food and drink containing 2,5-piperazinedione, 3,6-bis (phenylmethyl)-, (3S, 6S)-
AU2010334164B2 (en) * 2009-12-25 2014-09-11 Suntory Beverage & Food Asia Pte. Ltd. Learning motivation improvers
JP2011213700A (en) * 2010-04-02 2011-10-27 Nishizaki Soyaku Kenkyusho:Kk Composition for improving dementia
JP2012246224A (en) 2011-05-25 2012-12-13 Suntory Holdings Ltd Antidementia agent and learning and memory improver

Also Published As

Publication number Publication date
TWI620564B (en) 2018-04-11
CN104936597A (en) 2015-09-23
AU2013348836B2 (en) 2018-08-16
CN104936597B (en) 2019-01-11
KR102142168B1 (en) 2020-08-06
TW201436794A (en) 2014-10-01
AU2013348836A1 (en) 2015-07-02
GB201509976D0 (en) 2015-07-22
PH12015501115B1 (en) 2015-08-10
GB2523044B (en) 2019-03-27
NZ708648A (en) 2019-08-30
JP6291158B2 (en) 2018-03-14
PH12015501115A1 (en) 2015-08-10
GB2523044A (en) 2015-08-12
MY183914A (en) 2021-03-17
SG11201503967QA (en) 2015-06-29
JP2014101324A (en) 2014-06-05
HK1211212A1 (en) 2016-05-20
US9877960B2 (en) 2018-01-30
KR20150086357A (en) 2015-07-27
US20150297584A1 (en) 2015-10-22
WO2014080973A1 (en) 2014-05-30

Similar Documents

Publication Publication Date Title
PH12015501115B1 (en) Learning and memory improver
GB201211298D0 (en) Learning motivation improvers
MX2021001878A (en) Methods and compositions for enhancing cd4+ regulatory t cells.
EA030252B9 (en) Ph20 polypeptede variants, formulations and uses thereof
PH12014502602A1 (en) Methods for improving safety of blood-brain barrier transport
EP3441468A3 (en) Delivery methods and compositions for nuclease-mediated genome engineering
JO3343B1 (en) Novel5-aminotetrahydroquinoline-2-carboxylic acids and their use
IN2015DN03029A (en)
PH12015500900A1 (en) A stabilized pemetrexed formulation
MX2013004061A (en) Cyclosporin analogs.
IN2014DN08481A (en)
PH12015502118A1 (en) Pyridin-4-yl derivatives
IN2014DN06104A (en)
GB2519697A (en) Golf fitting systems and related methods
MX2013004062A (en) Cyclosporin analogs.
GEP201706739B (en) Compositions comprising vortioxetine and donepezil
MX2014008141A (en) Macrocyclic amides as protease inhibitors.
IN2014DN09585A (en)
PH12015501390A1 (en) Tablets with improved acceptance and good storage stability
WO2015108605A3 (en) Microbial production of branched medium chain alcohols, such as 4- methylpentanol
WO2012160713A8 (en) Learning and memory improver
PH12015500262A1 (en) Novel pyridine derivatives
IN2015MN00102A (en)
UA105703C2 (en) 7-bromo-5-phenyl-3-arylamino-1,2-dihydro-3h-1,4-benzdiazepin-2-ones as analgetic agents
UA92872C2 (en) combined antiaggregate and antioxidant drug